UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 9, 2006
MEDCO HEALTH SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
| | |
| 1-31312 | | 22-3461740 |
| (Commission File Number) | | (I.R.S. Employer Identification No.) |
| | |
| 100 Parsons Pond Drive, Franklin Lakes, NJ | | 07417 |
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: 201-269-3400
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01. Regulation FD Disclosure.
On January 9, 2006, the U.S. Justice Department filed notice that it has declined to intervene in a newqui tam action in which Medco Health Solutions, Inc. (the “Company”) is named as a defendant. The Company became aware of the newqui tam action on December 12, 2005 after the United States District Court for the Eastern District of Pennsylvania granted in part and denied in part a motion by an Assistant United States Attorney in the Eastern District of Pennsylvania to extend the seal and the evaluation period on the newqui tam action. While the District Court granted the motion to extend the evaluation period, it denied the request that the complaint remain under seal.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | |
| | | MEDCO HEALTH SOLUTIONS, INC. |
| | |
| Date: January 11, 2006 | | By: | | /s/ David S. Machlowitz
|
| | | | | David S. Machlowitz |
| | | | | Senior Vice President, |
| | | | | General Counsel and Secretary |
